Please provide your email address to receive an email when new articles are posted on . Intra-articular calcaneus fractures are high-energy injuries that can result in significant functional loss and ...

Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Discusses complications of an inadequately or unreduced zygomatic arch fracture. Considers various methods used for assessment of the reduction of zygomatic arch fractures intraoperatively. Describes ...

Mereo BioPharma (MREO) announced results from the Phase 3 ORBIT and COSMIC studies for setrusumab in Osteogenesis Imperfecta. Neither study ...

Please provide your email address to receive an email when new articles are posted on . Vertical shear pelvic ring injuries present a unique challenge due to their inherent vertical and rotational ...

Open reduction ankle surgery involves open surgery on fractured ankles. Doctors will realign ankle bones and may install internal fixations to keep them in place as they heal. Recovery from open ...

Angulated fractures involve a broken bone that tilts at an angle. Most cases require some form of realignment using a cast or other measures for proper healing. An angulated fracture occurs when a ...

Pharmaceutical announced results from the Phase 3 Orbit and Cosmic studies for setrusumab in Osteogenesis Imperfecta. Neither ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates ...